汉森制药

- 002412

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
汉森制药(002412) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入48,044.5825,403.2595,553.0868,414.1847,167.24
营业收入48,044.5825,403.2595,553.0868,414.1847,167.24
二、营业总成本37,997.6919,371.5878,424.3761,570.0141,511.91
营业成本12,199.136,544.5625,589.4218,786.4513,401.74
营业税金及附加958.10520.601,890.881,366.04942.10
销售费用20,075.6710,255.3739,468.3334,681.6222,700.70
管理费用2,759.561,221.396,835.723,524.592,227.91
财务费用91.8241.07192.10199.07123.58
研发费用1,913.43788.594,447.923,012.242,115.88
资产减值损失----------
公允价值变动收益80.8036.92179.60128.1990.05
投资收益1,181.01458.706,114.994,410.314,059.76
其中:对联营企业和合营企业的投资收益1,053.32399.975,775.194,110.203,844.60
汇兑收益----------
三、营业利润11,580.726,801.0623,493.7311,696.4710,011.84
加:营业外收入32.253.3762.5448.5435.37
减:营业外支出26.2310.72954.5436.1032.45
其中:非流动资产处置损失----------
四、利润总额11,586.736,793.7122,601.7311,708.9110,014.76
减:所得税费用1,537.33967.252,100.24734.68948.04
五、净利润10,049.405,826.4720,501.4910,974.239,066.72
归属于母公司所有者的净利润10,049.405,826.4720,501.4910,974.239,066.72
少数股东损益----------
六、每股收益
基本每股收益(元/股)0.19970.11580.40740.21810.1802
稀释每股收益(元/股)0.19970.11580.40740.21810.1802
七、其他综合收益1,406.81613.391,484.241,127.691,146.83
八、综合收益总额11,456.216,439.8521,985.7212,101.9210,213.54
归属于母公司所有者的综合收益总额11,456.216,439.8521,985.7212,101.9210,213.54
归属于少数股东的综合收益总额----------
下载全部历史数据到excel中 返回页顶